MCA
RGEN icon

Maryland Capital Advisors’s Repligen RGEN Stock Holding History

Maryland Capital Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48
Closed -$5.97K – 274
2025
Q2 		$5.97K Buy
+48
New +$6.11K ﹤0.01% 214

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Maryland Capital Advisors's RGEN Position: Q3 2025 in Review

Maryland Capital Advisors sold out of Repligen (RGEN) in Q3 2025, closing a stake of 48 shares — an estimated $5.97K sold.

Maryland Capital Advisors first reported a position in RGEN in Q2 2025 and held it in 1 quarter. The position peaked at $5.97K in Q2 2025. 452 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Maryland Capital Advisors reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Maryland Capital Advisors sold 48 Repligen shares in Q3 2025, an estimated $5.97K.
  • Maryland Capital Advisors first reported a position in Repligen in Q2 2025 and held it in 1 quarter.
  • Maryland Capital Advisors's Repligen position peaked at $5.97K in Q2 2025.
  • 452 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Maryland Capital Advisors's 13F filing for Q3 2025, filed 17 Oct 2025.